Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chow, E. J.
Right arrow Articles by Holly, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chow, E. J.
Right arrow Articles by Holly, E. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 155, No. 8 : 725-731
Copyright © 2002 by The Johns Hopkins University School of Hygiene and Public Health

ORIGINAL CONTRIBUTIONS

Blood Transfusions as a Risk Factor for Non-Hodgkin's Lymphoma in the San Francisco Bay Area: A Population-based Study

Eric J. Chow1 and Elizabeth A. Holly2,3

1 School of Medicine, University of California, San Francisco, CA.
2 Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, CA.
3 Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA.

The incidence of non-Hodgkin's lymphoma (NHL) has risen dramatically over the past 50 years. In the search for new risk factors, blood transfusions have been investigated and shown to be associated with subsequent lymphoma in some studies. The authors tested this association in a population-based, case-control study conducted between 1988 and 1995 in the San Francisco Bay Area of California. A total of 1,591 histologically confirmed adult cases of NHL were included in this study. Cases were frequency matched to 2,515 control participants by sex, county of residence, and 5-year age intervals. Multivariate logistic regression models were used to examine the impact of possible confounders. Persons who reported a history of allogeneic transfusion were not at increased risk of NHL in this population (odds ratio (OR) = 1.0, 95% confidence interval (CI): 0.84, 1.2). No significant associations were seen when lymphomas were stratified by histologic subtype, grade, or latency period. However, autologous transfusions were associated with a decreased risk (OR = 0.39, 95% CI: 0.16, 0.94). In summary, these findings are similar to those of prior negative studies and do not support some previous reports of an adverse association between blood transfusion and NHL.

blood transfusion; case-control studies; lymphoma, non-Hodgkin; risk factors

Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus; NHL, non-Hodgkin's lymphoma; OR, odds ratio


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
H. Hjalgrim, G. Edgren, K. Rostgaard, M. Reilly, T. N. Tran, K. E. Titlestad, A. Shanwell, C. Jersild, J. Adami, A. Wikman, et al.
Cancer Incidence in Blood Transfusion Recipients
J Natl Cancer Inst, December 19, 2007; 99(24): 1864 - 1874.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
P. M. Bracci, T. B. Dalvi, and E. A. Holly
Residential history, family characteristics and non-hodgkin lymphoma, a population-based case-control study in the san francisco bay area.
Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1287 - 1294.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. A. Clarke, D. M. Undurraga, P. J. Harasty, S. L. Glaser, L. M. Morton, and E. A. Holly
Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study.
Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 630 - 638.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
Y. Zhang, T. R. Holford, B. Leaderer, P. Boyle, S. H. Zahm, P. H. Owens, L. M. Morton, B. Zhang, K. Zou, S. Flynn, et al.
Blood Transfusion and Risk of Non-Hodgkin's Lymphoma in Connecticut Women
Am. J. Epidemiol., August 15, 2004; 160(4): 325 - 330.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. A. Clarke, S. L. Glaser, R. F. Dorfman, P. M. Bracci, E. Eberle, and E. A. Holly
Expert Review of Non-Hodgkin's Lymphomas in a Population-Based Cancer Registry: Reliability of Diagnosis and Subtype Classifications
Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 138 - 143.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
E. A. Holly and P. M. Bracci
Population-based Study of Non-Hodgkin Lymphoma, Histology, and Medical History among Human Immunodeficiency Virus-negative Participants in San Francisco
Am. J. Epidemiol., August 15, 2003; 158(4): 316 - 327.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
J. Zhu, K. Zhu, R. S. Levine, and L. S. Caplan
RE: "BLOOD TRANSFUSIONS AS A RISK FACTOR FOR NON-HODGKIN'S LYMPHOMA IN THE SAN FRANCISCO BAY AREA: A POPULATION-BASED STUDY"
Am. J. Epidemiol., June 1, 2003; 157(11): 1052 - 1052.
[Full Text] [PDF]

Home page
 Epidemiol RevHome page
E. J. Chow and E. A. Holly
Blood Transfusions and Non-Hodgkin's Lymphoma
Epidemiol. Rev., December 1, 2002; 24(2): 269 - 279.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.